FDA rejects MDMA, disappointing drugmaker Lykos and …
Aug 9, 2024 · On Friday, drugmaker Lykos Therapeutics received word from the Food and Drug Administration that the agency has decided not to approve MDMA-assisted therapy for PTSD …
After FDA rejection and layoffs, Lykos CEO is leaving
Sep 5, 2024 · The massive reorganization came in the aftermath of the FDA's rejection of Lykos’ MDMA candidate for post-traumatic stress disorder, plus …
Lykos will ask FDA to reconsider its decision following rejection of ...
Aug 10, 2024 · Following a poor showing for Lykos Therapeutics’ MDMA candidate for post-traumatic stress disorder at a recent FDA advisory committee meeting, the other shoe has …
- bing.com/videosWatch full video
Lykos Therapeutics Announces Complete Response Letter for ...
SAN JOSE, Calif., Aug. 9, 2024 /PRNewswire/ -- Lykos Therapeutics ("Lykos"), a company dedicated to transforming mental healthcare, announced that the U.S. Food and Drug …
Lykos Therapeutics - News Release Archive - News Releases
Aug 1, 2024 · Lykos Therapeutics ("Lykos"), a company dedicated to transforming mental healthcare, announced the outcome of the U.S. Food and Drug Administration's ("FDA") …
News Releases - Lykos
SAN JOSE, Calif., Feb. 9, 2024 / PRNewswire / -- Lykos Therapeutics (formerly MAPS Public Benefit Corporation) ("Lykos"), a company dedicated to transforming mental healthcare, …
- People also ask
FDA rejects MDMA-assisted therapy for PTSD - NBC News
Aug 9, 2024 · The Food and Drug Administration declined to approve MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder, drugmaker Lykos Therapeutics …
FDA rejects MDMA for treating PTSD, calls for redo of study
Aug 9, 2024 · Drugmaker Lykos Therapeutics had asked the FDA to approve its MDMA capsules as part of a therapy regimen they argued could be a breakthrough for treating challenging …
FDA declines to approve novel MDMA therapy to treat …
Aug 9, 2024 · The US Food and Drug Administration has declined to approve an application for the use of MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder, according to a news...
FDA won't approve psychedelic MDMA for PTSD | AP News
Aug 9, 2024 · Federal health officials have declined to approve the psychedelic drug MDMA as a therapy for PTSD. Drugmaker Lykos Therapeutics announced the FDA's decision on Friday.
